VITA, PATRIZIA
 Distribuzione geografica
Continente #
NA - Nord America 2091
EU - Europa 752
AS - Asia 351
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 1
SA - Sud America 1
Totale 3205
Nazione #
US - Stati Uniti d'America 1994
CN - Cina 327
DE - Germania 196
IT - Italia 182
UA - Ucraina 112
CA - Canada 96
SE - Svezia 73
GB - Regno Unito 55
FI - Finlandia 35
FR - Francia 30
IE - Irlanda 29
BE - Belgio 20
IN - India 12
PL - Polonia 10
EU - Europa 9
IR - Iran 8
AT - Austria 2
RO - Romania 2
AL - Albania 1
AR - Argentina 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
ES - Italia 1
HN - Honduras 1
ID - Indonesia 1
LB - Libano 1
NL - Olanda 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
RS - Serbia 1
TR - Turchia 1
Totale 3205
Città #
Jacksonville 289
Woodbridge 228
Chandler 201
Houston 173
Fairfield 168
Ann Arbor 146
Wilmington 99
Nanjing 81
Ashburn 76
Toronto 71
Seattle 66
Cambridge 59
San Mateo 54
Beijing 45
Nanchang 41
Lawrence 36
Princeton 36
Dearborn 30
Düsseldorf 30
Boardman 28
Dublin 27
Lachine 25
Brussels 20
Redwood City 20
Tianjin 20
Acquaviva 19
Hebei 19
Leawood 14
Shenyang 14
Kunming 13
Bremen 12
Camerino 12
Hangzhou 10
Jinan 10
Kraków 10
Nürnberg 10
Milan 9
Shanghai 9
Changchun 8
Changsha 8
Jiaxing 8
Ardabil 7
Mumbai 7
Augusta 6
Monmouth Junction 6
New York 6
Philadelphia 6
Venezia 6
Zhengzhou 6
Falls Church 5
Verona 5
Centro 4
Guangzhou 4
Hefei 4
Indiana 4
Lanzhou 4
Orange 4
Ardea 3
Chengdu 3
Fuzhou 3
Indianapolis 3
Montegiorgio 3
Ningbo 3
San Diego 3
Taizhou 3
Torre Del Greco 3
Arezzo 2
Auburn Hills 2
Berlin 2
Chicago 2
Enterprise 2
Fremont 2
Gunzenhausen 2
Helsinki 2
Latham 2
Manchester 2
Martinsicuro 2
Norwalk 2
San Francisco 2
Scafati 2
Tampa 2
Venice 2
Vienna 2
Albany 1
Ancona 1
Auckland 1
Bahawalpur 1
Belgrade 1
Bologna 1
Buffalo 1
Calcinelli 1
Catania 1
Chongqing 1
Clearwater 1
Copenhagen 1
Costa Mesa 1
Florence 1
Fort Lauderdale 1
Frankfurt am Main 1
Grafenhausen 1
Totale 2416
Nome #
Structure-Based Design, Synthesis and in vivo Antinociceptive Effects of Selective A1 Adenosine Receptor Agonists 146
Synthesis and biological activity of novel N6-substituted and 2,N6-disubstituted adenine ribo- and 3'-C-methyl-ribonucleosides as antitumor agents 141
Synthesis and Biological Evaluation of NAD Analogs as Human Pyridine Nucleotide Adenylyltransferase Inhibitors 135
Purine and pyrimidine nucleoside analogs of 3'-C-methyladenosine as antitumor agents 135
Novel Inhibitors of Inosine Monophosphate Dehydrogenase in Patent Literature of the Last Decade 127
Stereoselective synthesis of nicotinamide β-riboside and nucleoside analogs 126
Synthesis and antitumor activity of a heterodinucleotide of BVDU and Gemcitabine 125
From the covalent linkage of drugs to novel inhibitors of ribonucleotide reductase: synthesis and biological evaluation of valproic esters of 3'-C-methyladenosine 114
Ribose-modified mizoribine analogues: synthesis and biological evaluation 111
Inhibition of HIV-1 replication in macrophages by red blood cell-mediated delivery of a heterodinucleotide of lamivudine and tenofovir 108
Selective inhibition of nicotinamide adenine kinases (NADKs) by compact NAD mimics 103
5’-deoxy-5’-N-pyrazolyl-N6-substituded adenosine derivates as A1 adenosine receptor agonists: synthesis and antinociception in mice 102
5'-CHLORO-5'-DEOXY-N6-(±)-endo-NORBORNYLADENOSINE, A POTENT AND HIGHLY SELECTIVE HUMAN A1 ADENOSINE RECEPTOR AGONIST, PREVENTS HYPERALGESIA/ALLODYNIA AND EARLY OVER-EXPRESSION OF PRO-APOPTOTIC AND PRO-INFLAMMATORY GENES IN A MICE MODEL OF NEUROPATHIC PAIN 101
2’-C-Methyl derivatives of tecadenoson and 2-chloro-tecadenoson with increased selectivity for human A1 adenosine receptor 100
ADP- and ATP-mimetics derived from 2'(3')-C-methyladenosine as human P2Y1 and P2Y2 receptor ligands 95
ATP-mimetics derived from 2 '(3 ')-C-methyladenosine as human P2Y2 agonists 93
Antitumor effects of novel co-drugs linking histone deacetylase and ribonucleotide reductase inhibitors in hematological tumors 93
First TiCl4-Mediated Diastereoslective Reduction of alpha-Nitro Ketones to beta-Nitro Alcohols by BH3.SMe2 91
Synthesis and biological evaluation of (methylene)bisphosphonate derivatives of 2’-C-methyl-, and 3’-C-methyl-adenosine 86
Sugar-modified nucleosides: synthesis, conformational analysis and biological evaluation 85
5’-CHLORO-5’-DEOXY-N6-SUBSTITUTED ADENOSINE DERIVATIVES: SYNTHESIS, ADENOSINE RECEPTOR AFFINITY AND ANTINOCICEPTIVE ACTIVITY 80
Structure-affinity relathionships of 5'-carbamoyl- and 5'-thionocarbamoyl derivatives of the A1 selective adenosine receptor agonist 2'-MeCCPA as partial A1 agonists 78
N6/5’-DISUBSTITUTED ADENOSINE AND 2-CHLORO-ADENOSINE DERIVATIVES AS POTENT AND SELECTIVE A1 ADENOSINE RECEPTOR AGONISTS: SYNTHESIS, BINDING ASSAYS AND ANTINOCICEPTIVE ACTIVITY IN MICE 77
Synthesis and Enzymatic Evaluation of NAD Mimics as Nicotinamide Adenine Dinucleotide Kinase (NADK) Inhibitors 74
Affinity and selectivity of tecadenoson, 2-chloro-tecadenoson and 2’-C-methyl analogues at bovine and pig A1 adenosine receptor 70
5'-Chloro-5'-deoxy-N6-(±)-endo-norbornyladenosine, a potent and highly selective human A1 adenosine receptor agonist modulates neuropathic pain in mice. 70
NOVEL 2-SUBSTITUTED 2’/3’-C-METHYL-ADENOSINE DERIVATIVES: SYNTHESIS AND BIOLOGICAL EVALUATION AGAINST TRYPANOSOMA BRUCEI 69
EFFECTS OF METAL(III) COORDINATION ON BIOLOGICAL ACTIVITY OF 2,2'-BIPYRIDYL-6-CARBOTHIOAMIDE (BPYTA), A POTENT R2 RIBONUCLEOTIDE REDUCTASE INHIBITOR 68
N6/5’-DISUBSTITUTED ADENOSINE AND 2-CHLORO-ADENOSINE DERIVATIVES AS POTENT AND SELECTIVE A1 ADENOSINE RECEPTOR AGONISTS: SYNTHESIS, BINDING ASSAYS AND ANTINOCICEPTIVE ACTIVITY IN MICE 67
ADP-, and ATP-mimetics derived from 2'(3')-C-methyladenosine as human P2Y1 and P2Y2 ligands 65
Bisphosphonate Derivatives of 2’-C-Methyl-, and 3’-C-Methyl-Adenosine as Ligands at P2Y1 and P2Y2 Receptors 64
PROBING BINDING REQUIREMENTS OF NAD KINASE WITH MODIFIED NAD ANALOGUES 63
New N6-substituted adenosine and 3’-C-methyl-adenosine derivatives as antitumor agents 62
3’-C-Methyl-ribosyl nucleosides as cytotoxic compounds 62
Dual-target dimeric molecules with antitumor properties. Synthesis and biological activity of 3’-C-methyladenosine-valproates 54
Design, synthesis and biological evaluation of novel inhibitors of NAD kinase 50
Totale 3290
Categoria #
all - tutte 7267
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7267


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201888 0000 00 00 1343284
2018/2019411 9104 758 11110 1376986
2019/2020722 1023176109 3176 7669 41511545
2020/2021515 12471446 2429 7111 441414855
2021/2022354 25103620 1723 1123 30262941
2022/2023467 68153371 5377 645 99000
Totale 3290